| Product Code: ETC6738747 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Cancer Immunotherapy Drug Discovery Outsourcing Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, 2021 & 2031F |
3.3 China Cancer Immunotherapy Drug Discovery Outsourcing Market - Industry Life Cycle |
3.4 China Cancer Immunotherapy Drug Discovery Outsourcing Market - Porter's Five Forces |
3.5 China Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.6 China Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 China Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
4 China Cancer Immunotherapy Drug Discovery Outsourcing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and targeted therapies |
4.2.2 Rising incidence of cancer and the need for innovative treatment options |
4.2.3 Focus on cost reduction and efficiency in drug discovery processes |
4.3 Market Restraints |
4.3.1 Stringent regulatory environment and compliance requirements |
4.3.2 Limited availability of skilled professionals in cancer immunotherapy drug discovery |
4.3.3 High costs associated with research and development activities |
5 China Cancer Immunotherapy Drug Discovery Outsourcing Market Trends |
6 China Cancer Immunotherapy Drug Discovery Outsourcing Market, By Types |
6.1 China Cancer Immunotherapy Drug Discovery Outsourcing Market, By Service Type |
6.1.1 Overview and Analysis |
6.1.2 China Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Service Type, 2021- 2031F |
6.1.3 China Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Target Identification and Validation, 2021- 2031F |
6.1.4 China Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Lead Screening and Characterization, 2021- 2031F |
6.1.5 China Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Cell-based Assays, 2021- 2031F |
6.2 China Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 China Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Lung, 2021- 2031F |
6.2.3 China Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Breast, 2021- 2031F |
6.2.4 China Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Colorectal, 2021- 2031F |
6.2.5 China Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Melanoma, 2021- 2031F |
6.2.6 China Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Prostate, 2021- 2031F |
6.2.7 China Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Head and Neck, 2021- 2031F |
6.3 China Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 China Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Monoclonal Antibodies, 2021- 2031F |
6.3.3 China Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Immunomodulators, 2021- 2031F |
6.3.4 China Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Cancer Vaccines and Oncolytic Viral Therapy, 2021- 2031F |
7 China Cancer Immunotherapy Drug Discovery Outsourcing Market Import-Export Trade Statistics |
7.1 China Cancer Immunotherapy Drug Discovery Outsourcing Market Export to Major Countries |
7.2 China Cancer Immunotherapy Drug Discovery Outsourcing Market Imports from Major Countries |
8 China Cancer Immunotherapy Drug Discovery Outsourcing Market Key Performance Indicators |
8.1 Number of new partnerships and collaborations in the cancer immunotherapy drug discovery outsourcing market |
8.2 Percentage increase in research and development investments by pharmaceutical companies in China |
8.3 Growth in the number of clinical trials related to cancer immunotherapy drugs outsourcing in China |
9 China Cancer Immunotherapy Drug Discovery Outsourcing Market - Opportunity Assessment |
9.1 China Cancer Immunotherapy Drug Discovery Outsourcing Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.2 China Cancer Immunotherapy Drug Discovery Outsourcing Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 China Cancer Immunotherapy Drug Discovery Outsourcing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10 China Cancer Immunotherapy Drug Discovery Outsourcing Market - Competitive Landscape |
10.1 China Cancer Immunotherapy Drug Discovery Outsourcing Market Revenue Share, By Companies, 2024 |
10.2 China Cancer Immunotherapy Drug Discovery Outsourcing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here